RFX4 and neoplasm: Before injecting the cells into mice, we conducted proliferation and self-renewal assays in vitro to ensure that ANXA1-KO, HOPX-KO, and RFX4-KO cells exhibited no discernible advantages in growth or tumor-forming capabilities (Supplementary Fig. 10).